Fresenius Medical Care AG/ DE0005785802 /
12/5/2023 5:21:57 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.9250USD | - | 130 Turnover: 5,320.2500 |
-Bid Size: - | -Ask Size: - | 11.77 bill.USD | - | - |
GlobeNewswire
3/29/2022
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
GlobeNewswire
3/14/2022
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
GlobeNewswire
2/25/2022
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire
2/24/2022
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire
12/31/2021
CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire
12/9/2021
Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire
11/22/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
11/22/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
11/12/2021
Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire
10/27/2021
CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire
10/26/2021
Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...